Question
Question
When will the RSV monoclonal antibody nirsevimab (Beyfortus) no longer be in shortage in the US?
Resolved :Apr 1, 2024Total Forecasters11
Community Prediction2024-10-11
Make a Prediction
My Prediction
communitylower 25%
median
upper 75%
>2025-06-30
...
...
...
2024-08-05 17:08
2024-10-11 11:09
2025-01-05 12:33
5.7%
What was the final result?Apr 1, 2024
Community Baseline Score
-0.7
Community Peer Score
2.2
Authors:
Opened:
Closes:
Resolves:
Comments
? commentsAuthors:
Opened:
Closes:
Resolves: